LGALS3 and amyotrophic lateral sclerosis: Galectin-3 has been previously identified as a major proteomic hit up-regulated in tissue of transgenic SOD1G93A mice and ALS patients, and may contribute to regulate inflammatory features of microglia and serve as a disease biomarker [51, 52].